BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15744170)

  • 21. Serum protein profile analysis in patients with head and neck squamous cell carcinoma.
    Gourin CG; Xia ZS; Han Y; French AM; O'Rourke AK; Terris DJ; Adam BL
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):390-7. PubMed ID: 16618908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck.
    Mayer A; Andratschke M; Pauli C; Graefe H; Kristina K; Wollenberg B
    Anticancer Res; 2005; 25(6B):4075-80. PubMed ID: 16309201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
    Jonkman A; Kaanders JH; Terhaard CH; Hoebers FJ; van den Ende PL; Wijers OB; Verhoef LC; de Jong MA; Leemans CR; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):119-25. PubMed ID: 17448870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck.
    Lau H; Phan T; Mackinnon J; Matthews TW
    Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):257-61. PubMed ID: 18347249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered serum amino acid profiles in head and neck cancer.
    Scioscia KA; Snyderman CH; Wagner R
    Nutr Cancer; 1998; 30(2):144-7. PubMed ID: 9589433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study.
    Dahlstrom KR; Little JA; Zafereo ME; Lung M; Wei Q; Sturgis EM
    Head Neck; 2008 Jan; 30(1):75-84. PubMed ID: 17694557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
    Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
    Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
    Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inverse correlation between serum PGE2 and T classification in head and neck cancer.
    Hambek M; Baghi M; Wagenblast J; Schmitt J; Baumann H; Knecht R
    Head Neck; 2007 Mar; 29(3):244-8. PubMed ID: 17123309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma.
    Hsiung DT; Marsit CJ; Houseman EA; Eddy K; Furniss CS; McClean MD; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):108-14. PubMed ID: 17220338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
    Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
    Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
    Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q
    Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First safety and response results of a randomized phase III study with liposomal platin in the treatment of advanced squamous cell carcinoma of the head and neck (SCCHN).
    Jehn CF; Boulikas T; Kourvetaris A; Kofla G; Possinger K; Lüftner D
    Anticancer Res; 2008; 28(6B):3961-4. PubMed ID: 19192656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The usefulness of new serum tumor markers in head and neck squamous cell carcinoma.
    Marcos CA; Martínez DA; de Los Toyos JR; Domínguez Iglesias F; Hermsen M; Guervós MA; Pendás JL
    Otolaryngol Head Neck Surg; 2009 Mar; 140(3):375-80. PubMed ID: 19248946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of surface HLA class I levels in squamous cell carcinoma cell lines of the head and neck.
    Mandic R; Lieder A; Sadowski M; Peldszus R; Werner JA
    Anticancer Res; 2004; 24(2B):973-9. PubMed ID: 15161052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.